References
- Stockley RA. Alpha 1 antitrypsin deficiency: what next? Thorax 2000; 55:614–618.
- Devereux G. COPD: Definition, epidemiology and risk factors. BMJ 2006; 332(7550):1142–1144.
- Woolhouse IS, Bayley D, Stockley RA. Sputum chemotactic activity in chronic obstructive pulmonary disease; effect of alpha-1-antitrypsin deficiency and the role of leukotriene B4 and interleukin 8. Thorax 2002; 57:709–714.
- Stockley RA. Neutrophils and the pathogenesis of COPD. Chest 2002; 121:151S–155S.
- Dowson LJ, Guest PJ, Stockley RA. Longitudinal changes in physiological, radiological, and health status measurements in alpha-(1)-antitrypsin deficiency and factors associated with decline. Am J Respir Crit Care Med 2001; 164:1805–1809.
- Charman SC, Sharples LD, McNeil KD, Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transpl 2002; 21(2):226–232.
- Thabut G, Ravaud P, Christie JD, Castier Y, Fournier M, Mal H, Leseche G, Porcher R. Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177:1156–1163.
- Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 1998; 351:24–27.
- Stavem K, Bjortuft O, Borgan O, Geiran O, Boe J. Lung transplantation in patients wih chronic obstructive pulmonary disease in a national cohort is without survival benefit. J Heart Lung Transpl 2006; 25:75–84.
- Tanash HA, Riise GC, Hansson L, Nilsson PM, Piitulainen E. Survival benefit of lung transplantation in individuals with severe α1-antitrypsin deficiency (PiZZ) and emphysema. J Heart Lung Transplant 2011; 30(12) 1342–7.
- Banga A, Gildea T, Rajeswaran A, Rokadia H, Blackstone EH, Stoller JK. The natural history of lung function following lung transplantation for alpha-1-antitrypsin deficiency. Am J Respir Crit Care Med 2014; 190(3):247–281.
- Christie JD, Edwards LB, Kucheryavaya AY, Aurora P, Benden C, Dobbels F, Kirk R, Rahmel AO, Stehlik J, Hertz MI. The registry of the international society for heart and lung transplantation: 28th adult lung and heart-lung transplant report – 2011. J Heart Lung Transplant 2011; 30 (10):1104–1122.
- O'Brien C, Guest PG, Hill SL, Stockley RA. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000; 55(8):635–642.
- Parr DG, Guest PG, Reynolds JH, Dowson LJ, Stockley RA. Prevalence and impact of bronchiectasis in alpha-1-antitrypsin deficiency. Am J Respir Crit Care Med 2007; 176(12):1215–1221.
- International Guidelines for the Selection of Lung Transplant Candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society (ATS)/European Respiratory Society (ERS)/International Society for Heart and Lung Transplantation (ISHLT). Am J Respir Crit Care Med 1998; 158:335–339.
- Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, Egan T, Keshavjee S, Knoop C, Martinez FJ, Nathan S, Palmer S, Patterson A, Singer L, Snell G, Studer S, Vachiery JL, Ganville AR. International guidelines for the selection of lung transplant candidates: 2006 update —Consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transpl 2006; 25:745–755.
- Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body mass index, airflow obstruction, dyspnoea and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005–1012.
- Dawkins PA, Dowson LJ, Guest PJ, Stockley RA. Predictors of mortality in α1-antitrypsin deficiency. Thorax 2003; 58:1020–1026.